124 related articles for article (PubMed ID: 28615200)
1. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.
Magnen M; Gueugnon F; Guillon A; Baranek T; Thibault VC; Petit-Courty A; de Veer SJ; Harris J; Humbles AA; Si-Tahar M; Courty Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28615200
[TBL] [Abstract][Full Text] [Related]
2. Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.
Laporte M; Stevaert A; Raeymaekers V; Boogaerts T; Nehlmeier I; Chiu W; Benkheil M; Vanaudenaerde B; Pöhlmann S; Naesens L
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597759
[TBL] [Abstract][Full Text] [Related]
3. A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.
Straus MR; Whittaker GR
PLoS One; 2017; 12(3):e0174827. PubMed ID: 28358853
[TBL] [Abstract][Full Text] [Related]
4. ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
Heindl MR; Rupp A-L; Schwerdtner M; Bestle D; Harbig A; De Rocher A; Schmacke LC; Staker B; Steinmetzer T; Stein DA; Moulton HM; Böttcher-Friebertshäuser E
J Virol; 2024 Apr; 98(4):e0010224. PubMed ID: 38470058
[TBL] [Abstract][Full Text] [Related]
5. Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.
Sun X; Zeng H; Kumar A; Belser JA; Maines TR; Tumpey TM
J Virol; 2016 Dec; 90(24):11157-11167. PubMed ID: 27707929
[TBL] [Abstract][Full Text] [Related]
6. Mapping the interaction sites of human and avian influenza A viruses and complement factor H.
Rabeeah I; Billington E; Nal B; Sadeyen JR; Pathan AA; Iqbal M; Temperton NJ; Zipfel PF; Skerka C; Kishore U; Shelton H
Front Immunol; 2024; 15():1352022. PubMed ID: 38698856
[TBL] [Abstract][Full Text] [Related]
7. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
[TBL] [Abstract][Full Text] [Related]
8. Airway proteases: an emerging drug target for influenza and other respiratory virus infections.
Laporte M; Naesens L
Curr Opin Virol; 2017 Jun; 24():16-24. PubMed ID: 28414992
[TBL] [Abstract][Full Text] [Related]
9. Gene editing of pigs to control influenza A virus infections.
Kwon T; Artiaga BL; McDowell CD; Whitworth KM; Wells KD; Prather RS; Delhon G; Cigan M; White SN; Retallick J; Gaudreault NN; Morozov I; Richt JA
bioRxiv; 2024 Jan; ():. PubMed ID: 38293027
[TBL] [Abstract][Full Text] [Related]
10. Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.
Kido H; Okumura Y; Takahashi E; Pan HY; Wang S; Chida J; Le TQ; Yano M
J Mol Genet Med; 2008 Nov; 3(1):167-75. PubMed ID: 19565019
[TBL] [Abstract][Full Text] [Related]
11. Innate Antiviral Cytokine Response to Swine Influenza Virus by Swine Respiratory Epithelial Cells.
Bakre AA; Jones LP; Murray J; Reneer ZB; Meliopoulos VA; Cherry S; Schultz-Cherry S; Tripp RA
J Virol; 2021 Jul; 95(15):e0069221. PubMed ID: 33980596
[TBL] [Abstract][Full Text] [Related]
12. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding.
Qi L; Kash JC; Dugan VG; Jagger BW; Lau YF; Sheng ZM; Crouch EC; Hartshorn KL; Taubenberger JK
Virology; 2011 Apr; 412(2):426-34. PubMed ID: 21334038
[TBL] [Abstract][Full Text] [Related]
13. Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains.
Slepushkin VA; Staber PD; Wang G; McCray PB; Davidson BL
Mol Ther; 2001 Mar; 3(3):395-402. PubMed ID: 11273782
[TBL] [Abstract][Full Text] [Related]
14. The clinically used serine protease inhibitor nafamostat reduces influenza virus replication and cytokine production in human airway epithelial cells and viral replication in mice.
Yamaya M; Shimotai Y; Ohkawara A; Bazarragchaa E; Okamatsu M; Sakoda Y; Kida H; Nishimura H
J Med Virol; 2021 Jun; 93(6):3484-3495. PubMed ID: 33247612
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of influenza a virus infection by natural stilbene piceatannol targeting virus hemagglutinin.
Huang L; Wang J; Ma X; Sun L; Hao C; Wang W
Phytomedicine; 2023 Nov; 120():155058. PubMed ID: 37690231
[TBL] [Abstract][Full Text] [Related]
16. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
Kido H; Murakami M; Oba K; Chen Y; Towatari T
Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
[TBL] [Abstract][Full Text] [Related]
17. FcγRIIB modulates splenic germinal center response against immune subversion during acute influenza A virus infection.
Wu YH; Chang WT; Hsu CL; Lu YF; Wang JT; Tzeng SJ
J Microbiol Immunol Infect; 2024 Feb; 57(1):64-75. PubMed ID: 38087748
[TBL] [Abstract][Full Text] [Related]
18. Mouse dendritic cell (DC) influenza virus infectivity is much lower than that for human DCs and is hemagglutinin subtype dependent.
Hartmann BM; Li W; Jia J; Patil S; Marjanovic N; Martínez-Romero C; Albrecht RA; Hayot F; García-Sastre A; Wetmur JG; Moran TM; Sealfon SC
J Virol; 2013 Feb; 87(3):1916-8. PubMed ID: 23192878
[TBL] [Abstract][Full Text] [Related]
19. The pro-inflammatory response to influenza A virus infection is fueled by endothelial cells.
Bauer L; Rijsbergen LC; Leijten L; Benavides FF; Noack D; Lamers MM; Haagmans BL; de Vries RD; de Swart RL; van Riel D
Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37072183
[TBL] [Abstract][Full Text] [Related]
20. Seasonal influenza viruses decay more rapidly at intermediate humidity in droplets containing saliva compared to respiratory mucus.
Rockey NC; Le Sage V; Marr LC; Lakdawala SS
Appl Environ Microbiol; 2024 Feb; 90(2):e0201023. PubMed ID: 38193683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
